Cargando…

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4

Bluetongue virus (BTV) replicates in lymphoid tissues where infected mononuclear leukocytes secrete proinflammatory and vasoactive mediators that can contribute to bluetongue (BT) pathogenesis. Using the well-characterized IFNAR(-/-) mice animal model, we have now studied the histopathology and dyna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marín-López, Alejandro, Bermúdez, Roberto, Calvo-Pinilla, Eva, Moreno, Sandra, Brun, Alejandro, Ortego, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166487/ https://www.ncbi.nlm.nih.gov/pubmed/27994510 http://dx.doi.org/10.7150/ijbs.14967

Ejemplares similares

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

Viral Vector Vaccines against Bluetongue Virus
por: Jiménez-Cabello, Luis, et al.
Publicado: (2020)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
por: Moreno, Sandra, et al.
Publicado: (2020)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor
por: Calvo-Pinilla, Eva, et al.
Publicado: (2009)

Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
por: Marín-Lopez, Alejandro, et al.
Publicado: (2019)

Virological, immunological and pathological findings of transplacentally transmitted bluetongue virus serotype 1 in IFNAR1-blocked mice during early and mid gestation
por: Saminathan, M., et al.
Publicado: (2020)

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
por: Calvo-Pinilla, Eva, et al.
Publicado: (2012)

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2020)

The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2(1-180)) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2022)

Increased Clinical Signs and Mortality in IFNAR((−/−)) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype
por: Attoui, Houssam, et al.
Publicado: (2023)

Identification and Characterization of Bluetongue Virus Serotype 14 in Russia
por: Koltsov, Andrei, et al.
Publicado: (2020)

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice
por: Saminathan, Mani, et al.
Publicado: (2021)

Transplacental Transmission of Bluetongue Virus Serotype 1 and Serotype 8 in Sheep: Virological and Pathological Findings
por: van der Sluijs, Mirjam T. W., et al.
Publicado: (2013)

A novel Schmallenberg virus subunit vaccine candidate protects IFNAR(-/-) mice against virulent SBV challenge
por: Boshra, Hani, et al.
Publicado: (2020)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

Western Bluetongue virus serotype 3 in Sardinia, diagnosis and characterization
por: Cappai, S., et al.
Publicado: (2019)

Experimental bluetongue virus superinfection in calves previously immunized with bluetongue virus serotype 8
por: Martinelle, Ludovic, et al.
Publicado: (2016)

Epidemiology of Bluetongue Virus Serotype 8, Germany
por: Conraths, Franz J., et al.
Publicado: (2009)

Novel Bluetongue Virus Serotype from Kuwait
por: Maan, Sushila, et al.
Publicado: (2011)

Reassortment of bluetongue virus vaccine serotypes in cattle
por: van den Bergh, Carien, et al.
Publicado: (2018)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: López-Gil, Elena, et al.
Publicado: (2020)

Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR (−/−) mice
por: Fay, Petra C., et al.
Publicado: (2019)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

A model for the assessment of bluetongue virus serotype 1 persistence in Spain
por: Aguilar-Vega, Cecilia, et al.
Publicado: (2020)

Multiple Serotypes of Bluetongue Virus in Sheep and Cattle, Israel
por: Brenner, Jacob, et al.
Publicado: (2010)

Novel Serotype of Bluetongue Virus, Western North America
por: Maclachlan, N. James, et al.
Publicado: (2013)

First detection of bluetongue virus serotype 14 in Poland
por: Orłowska, Anna, et al.
Publicado: (2016)

Co-Circulation of Multiple Serotypes of Bluetongue Virus in Zambia
por: Chambaro, Herman M., et al.
Publicado: (2020)

Association of IFNAR1 and IFNAR2 with COVID-19 severity
por: Yaugel-Novoa, Melyssa, et al.
Publicado: (2023)

Risk‐based serological survey of bluetongue and the first evidence of bluetongue virus serotype 26 circulation in Tunisia
por: Sana, Kalthoum, et al.
Publicado: (2022)

Evidence for Transmission of Bluetongue Virus Serotype 26 through Direct Contact
por: Batten, Carrie, et al.
Publicado: (2014)

Identification and genomic characterization of the first isolate of bluetongue virus serotype 5 detected in Australia
por: White, John R., et al.
Publicado: (2019)

Characterization of local SARS-CoV-2 isolatesand pathogenicity in IFNAR(−/-) mice
por: Hanifehnezhad, Alireza, et al.
Publicado: (2020)

Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes
por: Jyothi, Shiva J., et al.
Publicado: (2020)

Bluetongue Virus Serotype 8 Reemergence in Germany, 2007 and 2008
por: Hoffmann, Bernd, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j8a4r62mgrlpk0d688tofcjv6t